SI1185536T1 - Hemisynthetic method and intermediates thereof - Google Patents

Hemisynthetic method and intermediates thereof

Info

Publication number
SI1185536T1
SI1185536T1 SI200030599T SI200030599T SI1185536T1 SI 1185536 T1 SI1185536 T1 SI 1185536T1 SI 200030599 T SI200030599 T SI 200030599T SI 200030599 T SI200030599 T SI 200030599T SI 1185536 T1 SI1185536 T1 SI 1185536T1
Authority
SI
Slovenia
Prior art keywords
intermediates
hemisynthetic
hemisynthetic method
Prior art date
Application number
SI200030599T
Other languages
English (en)
Slovenian (sl)
Inventor
Carmen Pharma Mar S.A. Calle De La Cuevas
Marta Pharma Mar S.A. Calle De La Perez
Andres Pharma Mar S.A. Calle de la FRANCESCH
Carolina Pharma Mar S.A. Calle de la FERNANDEZ
Jose Luis Pharma Mar S.A. Calle de la CHICHARRO
Pilar Pharma Mar S.A. Calle De La Gallego
Maria Pharma Mar S.A. Calle de la ZARZUELO
La Calle Fernando Pharma Mar S.A. Calle De De
Ignacio Pharma Mar S.A. Calle De La Manzanares
Original Assignee
Pharma Mar, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9911345.8A external-priority patent/GB9911345D0/en
Priority claimed from GBGB9918178.6A external-priority patent/GB9918178D0/en
Priority claimed from GBGB9923632.5A external-priority patent/GB9923632D0/en
Priority claimed from GB0001063A external-priority patent/GB0001063D0/en
Application filed by Pharma Mar, S.A. filed Critical Pharma Mar, S.A.
Publication of SI1185536T1 publication Critical patent/SI1185536T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SI200030599T 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof SI1185536T1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9911345.8A GB9911345D0 (hu) 1999-05-14 1999-05-14
GBGB9918178.6A GB9918178D0 (en) 2000-05-15 1999-08-02 Synthetic methods
GBGB9923632.5A GB9923632D0 (en) 1999-10-06 1999-10-06 Hemisynthetic process towards ecteinascidin and phtalscidin compounds
GB0001063A GB0001063D0 (en) 2000-01-17 2000-01-17 Hemisynthetic process towards ecteinascidin and phtalascidin
PCT/GB2000/001852 WO2000069862A2 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof

Publications (1)

Publication Number Publication Date
SI1185536T1 true SI1185536T1 (en) 2005-06-30

Family

ID=42632476

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200030599T SI1185536T1 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof
SI200130399T SI1287004T1 (sl) 1999-05-14 2001-05-15 Sinteticni postopek za proizvodnjo spojine ekteinascidina

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200130399T SI1287004T1 (sl) 1999-05-14 2001-05-15 Sinteticni postopek za proizvodnjo spojine ekteinascidina

Country Status (30)

Country Link
US (3) US7241892B1 (hu)
EP (1) EP1185536B1 (hu)
JP (1) JP4445136B2 (hu)
KR (1) KR100834601B1 (hu)
CN (3) CN1229382C (hu)
AR (1) AR035842A1 (hu)
AT (1) ATE283273T1 (hu)
AU (2) AU775580B2 (hu)
BG (1) BG65896B1 (hu)
BR (3) BRPI0010559B8 (hu)
CA (2) CA2372058C (hu)
CY (1) CY1108095T1 (hu)
CZ (3) CZ303536B6 (hu)
DE (1) DE60016209T2 (hu)
DK (1) DK1185536T3 (hu)
ES (2) ES2233367T3 (hu)
HK (1) HK1047432A1 (hu)
HU (1) HU230646B1 (hu)
MX (1) MXPA01011631A (hu)
MY (1) MY130271A (hu)
NO (2) NO322016B1 (hu)
NZ (1) NZ515424A (hu)
PL (1) PL226890B1 (hu)
PT (1) PT1185536E (hu)
RU (1) RU2237063C9 (hu)
SI (2) SI1185536T1 (hu)
SK (2) SK287835B6 (hu)
TR (1) TR200103273T2 (hu)
UA (1) UA75333C2 (hu)
WO (3) WO2000069862A2 (hu)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200003470T2 (tr) 1998-05-11 2001-06-21 Pharama Mar, S.A. Ecteinascidin 743 Metabolitleri
MY164077A (en) 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
AR035842A1 (es) 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
US7919493B2 (en) 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
DE60111845T2 (de) * 2000-04-12 2006-04-27 Pharma Mar, S.A., Tres Cantos Ecteinaschidin derivate mit antikrebs wirkung
JP4942900B2 (ja) * 2000-05-15 2012-05-30 ファルマ・マール・ソシエダード・アノニマ エクチナサイジン化合物の製造のための合成方法
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US7420051B2 (en) 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
WO2002040477A2 (en) 2000-11-03 2002-05-23 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
JP4391083B2 (ja) * 2000-11-06 2009-12-24 ファルマ・マール・ソシエダード・アノニマ 効果的な抗腫瘍治療
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
WO2003039571A1 (en) * 2001-10-19 2003-05-15 Pharmamar S.A. Improved use of antitumoral compound in cancer therapy
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0229793D0 (en) * 2002-12-20 2003-01-29 Pharma Mar Sa The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
US7183054B2 (en) 2003-06-03 2007-02-27 President And Fellows Of Harvard College Assay for identifying biological targets of polynucleotide-binding compounds
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
DE602004016376D1 (de) * 2003-11-13 2008-10-16 Pharma Mar Sau Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
WO2005049030A1 (en) * 2003-11-14 2005-06-02 Pharma Mar, S.A. Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
WO2006035244A2 (en) * 2004-09-29 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
US20090117176A1 (en) * 2004-10-26 2009-05-07 Pharma Mar, S.A. Sociedad Unipersonal Anticancer Treatments
RU2382647C2 (ru) * 2004-10-29 2010-02-27 Фарма Мар С.А., Сосьедад Униперсональ Композиции, содержащие эктинэсайдин и дисахарид
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
KR100712667B1 (ko) 2006-04-11 2007-05-02 재단법인서울대학교산학협력재단 신규한 디아자 헤테로고리 유도체 및 그의 고체상 제조방법
GB0708691D0 (en) * 2007-05-04 2007-06-13 Pharma Mar Sa Anticancer treatments a
US20090076017A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched trabectedin
CA2703026A1 (en) * 2007-10-19 2009-04-23 Rafael Rosell Costa Prognostic molecular markers for et-743 treatment
CA2724325A1 (en) * 2008-05-16 2009-11-19 Pharma Mar, S.A. Combination therapy with an antitumor alkaloid
JP2011520846A (ja) * 2008-05-16 2011-07-21 ファルマ・マール・ソシエダード・アノニマ 多発性骨髄腫の治療
WO2011048210A1 (en) 2009-10-22 2011-04-28 Pharma Mar, S.A. PDGFR-α AS RESPONSE MARKER FOR PM00104 TREATMENT
CA2800097C (en) 2010-05-25 2019-01-08 Pharma Mar, S.A. Synthetic process for the manufacture of ecteinascidin compounds and intermediates
LT2786753T (lt) 2010-11-12 2019-04-10 Pharma Mar S.A. Derinių terapija su antinavikiniu antibiotiku
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN107739387B (zh) * 2017-10-16 2020-01-03 上海皓元生物医药科技有限公司 一种制备曲贝替定的关键中间体化合物的方法
CN109912629B (zh) * 2017-12-13 2021-12-24 浙江中科创越药业有限公司 天然产物Trabectedin的制备
TWI824043B (zh) 2018-10-25 2023-12-01 西班牙商瑪製藥股份有限公司 藥物抗體共軛物
CN111518110B (zh) * 2019-02-01 2023-11-03 博瑞生物医药（苏州）股份有限公司 一种海鞘素化合物及其中间体的制备方法
CN111620792B (zh) * 2019-02-28 2023-01-03 兰州大学 一种n,n-二取代氰基甲酰胺的合成方法
CN116217584A (zh) * 2021-12-06 2023-06-06 南通诺泰生物医药技术有限公司 Et743及其中间体的光催化合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461995A1 (fr) * 1979-07-20 1981-02-06 Lcc Cice Cie Europ Compo Elect Transducteur magneto-electrique pour systeme d'enregistrement magnetique, et systeme d'enregistrement comportant un tel transducteur
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
JPS6054386A (ja) * 1983-09-02 1985-03-28 Yoshitomi Pharmaceut Ind Ltd サフラシン誘導体
JPS6084288A (ja) 1983-10-13 1985-05-13 Shionogi & Co Ltd シアノキノナミンアセテ−ト類およびその製造法
US5149804A (en) 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
AU589282B2 (en) 1986-06-09 1989-10-05 University Of Illinois Ecteinascidins 729, 743, 745, 759a, 759b and 770
US5089273A (en) 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5256663A (en) 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5478932A (en) 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US5985876A (en) 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
JP4443043B2 (ja) * 1998-04-06 2010-03-31 ザ ボード オブ トラスティーズ オブ ザ ユニバーシテイ オブ イリノイ 半合成エクテイナシジン
TR200003470T2 (tr) 1998-05-11 2001-06-21 Pharama Mar, S.A. Ecteinascidin 743 Metabolitleri
US6124292A (en) 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
AR035842A1 (es) 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
US6686470B2 (en) 2000-01-19 2004-02-03 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
DE60111845T2 (de) 2000-04-12 2006-04-27 Pharma Mar, S.A., Tres Cantos Ecteinaschidin derivate mit antikrebs wirkung
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.

Also Published As

Publication number Publication date
SK287835B6 (sk) 2011-12-05
MY130271A (en) 2007-06-29
BRPI0110443B8 (pt) 2021-05-25
BRPI0110801B1 (pt) 2018-02-27
CZ304973B6 (cs) 2015-02-25
KR100834601B1 (ko) 2008-06-02
RU2237063C9 (ru) 2008-10-10
NO328301B1 (no) 2010-01-25
ATE283273T1 (de) 2004-12-15
EP1185536A2 (en) 2002-03-13
PL353002A1 (en) 2003-09-22
CZ303536B6 (cs) 2012-11-21
CN100475822C (zh) 2009-04-08
CZ20023751A3 (en) 2004-05-12
AU5649601A (en) 2001-11-26
HUP0201188A2 (en) 2002-07-29
DK1185536T3 (da) 2005-04-04
SK15272002A3 (sk) 2003-06-03
CA2372058A1 (en) 2000-11-23
CN1360588A (zh) 2002-07-24
CN1211386C (zh) 2005-07-20
WO2000069862A3 (en) 2001-03-22
JP4445136B2 (ja) 2010-04-07
BG65896B1 (bg) 2010-04-30
JP2002544280A (ja) 2002-12-24
CA2406095C (en) 2010-02-16
US20040002602A1 (en) 2004-01-01
BR0110801A (pt) 2003-02-11
CN1440414A (zh) 2003-09-03
DE60016209D1 (de) 2004-12-30
NZ515424A (en) 2004-06-25
US7524956B2 (en) 2009-04-28
BR0110443A (pt) 2003-04-08
SK287879B6 (sk) 2012-02-03
WO2001087894A1 (en) 2001-11-22
CY1108095T1 (el) 2014-02-12
DE60016209T2 (de) 2005-12-15
BRPI0010559B1 (pt) 2016-08-30
SI1287004T1 (sl) 2005-12-31
BG107301A (bg) 2003-07-31
US7241892B1 (en) 2007-07-10
ES2233367T3 (es) 2005-06-16
PL226890B1 (pl) 2017-09-29
CA2406095A1 (en) 2001-11-22
UA75333C2 (uk) 2006-04-17
PT1185536E (pt) 2005-04-29
AR035842A1 (es) 2004-07-21
MXPA01011631A (es) 2002-07-30
CA2372058C (en) 2010-10-26
NO20015547L (no) 2002-01-14
AU4597300A (en) 2000-12-05
NO20025186D0 (no) 2002-10-29
CZ20023746A3 (cs) 2003-04-16
TR200103273T2 (tr) 2002-04-22
WO2000069862A2 (en) 2000-11-23
SK16502001A3 (sk) 2002-06-04
RU2237063C2 (ru) 2004-09-27
EP1185536B1 (en) 2004-11-24
WO2001087895A1 (en) 2001-11-22
BR0010559A (pt) 2002-07-02
CZ304966B6 (cs) 2015-02-18
BRPI0010559B8 (pt) 2021-05-25
US20080045713A1 (en) 2008-02-21
BRPI0110443B1 (pt) 2018-06-26
ES2231486T3 (es) 2005-05-16
BRPI0110801B8 (pt) 2021-05-25
HU230646B1 (hu) 2017-05-29
NO20015547D0 (no) 2001-11-13
HK1047432A1 (en) 2003-02-21
NO322016B1 (no) 2006-08-07
KR20020021636A (ko) 2002-03-21
CN1229382C (zh) 2005-11-30
CN1441805A (zh) 2003-09-10
AU775580B2 (en) 2004-08-05
CZ20014102A3 (cs) 2002-06-12
NO20025186L (no) 2003-01-14

Similar Documents

Publication Publication Date Title
PL353002A1 (en) Hemisynthetic method and intermediates thereof
GB9918031D0 (en) Method
GB9916757D0 (en) Method
GB0007871D0 (en) Method
GB9915036D0 (en) Method of imputting text
GB9915625D0 (en) Method
GB9924752D0 (en) Method of construction
GB9919370D0 (en) Method
HU0002285D0 (en) Novel processes and intermediates
GB2355455B (en) Method
GB9915936D0 (en) Method
GB9920334D0 (en) Method
GB9924399D0 (en) Method
GB9919362D0 (en) Novel method and compounds
GB9905518D0 (en) Novel method and compound
PL336550A1 (en) Method of decoposing 2-chloroethenylchloroarsazine
GB9929493D0 (en) Composition and method
GB9917409D0 (en) Composition and method
GB9903934D0 (en) Method
GB9917345D0 (en) Method
GB9911937D0 (en) Method
GB9911682D0 (en) Method
GB0007867D0 (en) Method
GB9921850D0 (en) Method
GB9906056D0 (en) Method